ArticleDermatology and therapy2022

Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure.

Christopher E M Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.